Defying death: Japan and Singapore lead Asia’s stem cell research race

by admin | Aug 23, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

A continental race within a global race? Here’s the byline- “In the world’s fastest-aging societies, regenerative therapies attract the rich and curious.” There’s way too much info to unpack from from this lengthy article from...

This startup wants to copy you into an embryo for organ harvesting

by admin | Aug 8, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Antonio Regalado – MIT Technology Review With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics. The company, Renewal Bio, is pursuing recent advances in stem-cell technology and...

Artificial Intelligence Enters Stem Cell Research

by admin | Aug 5, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Written by: Foley & Lardner LLP – JDSupra.com A major step forward in using Artificial Intelligence (AI) for scientific discovery in the field of stem cell research was recently reported1, reflecting the continued growth of the technology and stressing the...

Scientists Partially Revived Pig Organs An Hour After Death In ‘Stunning’ New Research

by admin | Aug 4, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Here’s a headline you don’t see every day. Stunning- #organs revived after death! Could this one day be an answer to organ shortages? Or a plot straight out of a dystopian TV show on the SyFy Channel. Article in #Forbes provides the...

Ageing and rejuvenation of tissue stem cells and their niches

by admin | Aug 4, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Abstract Most adult organs contain regenerative stem cells, often organized in specific niches. Stem cell function is critical for tissue homeostasis and repair upon injury, and it is dependent on interactions with the niche. During ageing, stem cells decline in their...

An abundance of CAR-Ts: B cell therapy cancer market can’t support ‘congested’ pipeline, report says

An abundance of CAR-Ts: $37B cell therapy cancer market can’t support ‘congested’ pipeline, report says

by admin | Aug 3, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Image caption: Market over-saturation is especially pronounced in acute lymphocytic leukemia, which has more than 300 drugs in the pipeline, plus two that boast FDA approvals, GlobalData points out. (Mohammed Haneefa Nizamudeen/iStock/Getty Images Plus) By Fraiser...